+ Watch OPK
on My Watchlist
I like the up-look color and diversity of products both in the near and those in the pipeline. No one can argue the success nor the brilliance of Dr. Frost.
Outperform over the next 5 years. I hold a small position on this one as a bet on Phillip Frost continuing the home runs he hit in the past. He ran two other small pharmas in the past, which he built into successful companies and sold at nice profits. At $8.31 per share, my investment is so small, I can afford to sit on this one. It will never make me rich but I am counting on a nice profit down the road and a fun ride along the way.
CEO and serial monopolist Phillip Frost is buying like there is no tomorrow. He seems to know what he is doing, which will allow him to donate to many more music schools and museums when he dies.
Insider and Institutional ownership looks great. CEO purchases upwards of 15,000 shares every day like an animal which adds volume and liquidity. Orphan drug not a huge deal, but offers benefits nonetheless. Prostate testing methods should be announced here by the end of the month. Over 21% short float makes for a bull day that could sustain above resistance. Price target of 12.33, I believe it should be higher. I believe I read somewhere there prostate testing method has been being used in Europe but they haven't reported there profits from that? Either way it should be making its debut here in the US in the next few months. Busted out of a slanted double bottom very strongly, and has all its moving averages doing a synchronized dance to their preferred positions. Something major is brewing with the overwhelmingly heavy insider transactions over the past year. His purchases will consistently drive the price up along with little short squeezes in some way shape or form and should be viewed in bullish terms. Humongous pipeline and financials are looking good. Outperform both short and long term.
it moving I bought at 6
Lots of big news comming in next several months. Huge Pipeline!
at least one medicine will go live
Buying this selloff and looking for next year to be huge
Frost is in the business of making money! His track record speaks for itself.
OPKO Health Inc. has a big year ahead of it. The 4Kscore™ Prostate Cancer Test is a revolutionary development in the medical field. It allows a health professional to create a detailed assessment rating of a male patient's risk for developing prostate cancer. Not only is this less invasive than traditional methods, but overall it will create a large cost savings by decreasing the amount of expensive biopsies conducted. This tool has the potential to create a better system of patient assessment, help health professionals find signs of prostate cancer in the earliest stages, decrease fatalities, increase patient compliance because of its non-invasive nature, and decrease the cost of health care. OPKO Health Inc. has a bright future ahead of it. I am excited to see what other innovative technologies they can bring the forefront of of the health care system not only in the U.S but also throughout the world.
Pipeline emerges in the next couple of years. Beginning in 2014.
A vote of confidence in Dr. Frost.
Frost run company
tight progressive and innovative leadership..with major ownership investment and in the company
I think that OPK has alot of potential to the upside. It is trying to establish a foothold in a great industry and has made some aquisitions that will help in the near ftrure. I would buy this and hold to see if other investors have the same thoughts.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions